Federal Register / Vol. 79, No. 202 / Monday, October 20, 2014 / Notices 62641 

whiteld@niehs.nih.gov. TTY users 

should contact the Federal TTY Relay 

Service at 800–877–8339. Requests 

should be made at least five business 

days in advance of the event. 

Request for Comments: Written 

comments submitted in response to this 

notice should be received by November 

25, 2014. Comments will be posted on 

the BSC meeting Web site and persons 

submitting them will be identified by 

their name and affiliation and/or 

sponsoring organization, if applicable. 

Persons submitting written comments 

should include their name, affiliation (if 

applicable), phone, email, and 

sponsoring organization (if any) with 

the document. 

Time is allotted during the meeting 

for the public to present oral comments 

to the BSC on the agenda topics. Public 

comments can be presented in-person at 

the meeting or by teleconference line. 

There are 50 lines for this call; 

availability is on a first-come, firstserved basis. The lines will be open on 

December 10 from 9:00 a.m. until 

adjournment, although the BSC will 

receive public comments only during 

the formal public comment periods, 

which are indicated on the preliminary 

agenda. Each organization (sponsoring 

organization or affiliation) is allowed 

one time slot per agenda topic. Each 

speaker is allotted at least 7 minutes, 

which if time permits, may be extended 

to 10 minutes at the discretion of the 

BSC chair. Persons wishing to present 

oral comments should register on the 

BSC meeting Web site by December 2, 

2014, indicate whether they will present 

comments in-person or via the 

teleconference line, and indicate the 

topic(s) on which they plan to comment. 

The access number for the 

teleconference line will be provided to 

registrants by email prior to the meeting. 

On-site registration for oral comments 

will also be available on the meeting 

day, although time allowed for 

comments by these registrants may be 

limited and will be determined by the 

number of persons who register at the 

meeting. 

Persons registering to make oral 

comments are asked to send a copy of 

their statement and/or PowerPoint 

slides to the Designated Federal Officer 

by December 2, 2014. Written 

statements can supplement and may 

expand upon the oral presentation. If 

registering on-site and reading from 

written text, please bring 20 copies of 

the statement for distribution to the BSC 

and NTP staff and to supplement the 

record. 

Background Information on the BSC: 

The BSC is a technical advisory body 

comprised of scientists from the public 

and private sectors that provides 

primary scientific oversight to the NTP. 

Specifically, the BSC advises the NTP 

on matters of scientific program content, 

both present and future, and conducts 

periodic review of the program for the 

purpose of determining and advising on 

the scientific merit of its activities and 

their overall scientific quality. Its 

members are selected from recognized 

authorities knowledgeable in fields such 

as toxicology, pharmacology, pathology, 

biochemistry, epidemiology, risk 

assessment, carcinogenesis, 

mutagenesis, molecular biology, 

behavioral toxicology, neurotoxicology, 

immunotoxicology, reproductive 

toxicology or teratology, and 

biostatistics. Members serve overlapping 

terms of up to four years. The BSC 

usually meets biannually. The authority 

for the BSC is provided by 42 U.S.C. 

217a, section 222 of the Public Health 

Service Act (PHS), as amended. The 

BSC is governed by the provisions of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. app.), which sets 

forth standards for the formation and 

use of advisory committees. 

Dated: October 14, 2014. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2014–24783 Filed 10–17–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; 

Cerebrovascular Disease and Aging. 

Date: November 10, 2014. 

Time: 1:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, Suite 2C212, 7201 

Wisconsin Avenue, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Ramesh Vemuri, Ph.D., 

Chief, Scientific Review Branch, National 

Institute on Aging, National Institutes of 

Health, 7201 Wisconsin Avenue, Suite 2C– 

212, Bethesda, MD 20892, 301–402–7700, 

rv23r@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: October 14, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–24789 Filed 10–17–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Pathophysiology of Neurological 

Disorders. 

Date: November 10, 2014. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Boris P Sokolov, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217A, 

MSC 7846, Bethesda, MD 20892, 301–408– 

9115, bsokolov@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Fellowship: 

Physiology and Pathobiology of 

Musculoskeletal, Oral, and Skin Systems. 

Date: November 12, 2014. 

Time: 8:00 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 


tkelley on DSK3SPTVN1PROD with NOTICES
62642 Federal Register / Vol. 79, No. 202 / Monday, October 20, 2014 / Notices 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Anshumali Chaudhari, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4124, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1210, chaudhaa@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Drug 

Discovery for the Nervous System. 

Date: November 12, 2014. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Geoffrey G Schofield, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040–A, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1235, geoffreys@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group; 

Behavioral and Social Science Approaches to 

Preventing HIV/AIDS Study Section. 

Date: November 13–14, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Fairmont Washington, DC 

Georgetown, 2401 M Street NW., 

Washington, DC 20037. 

Contact Person: Jose H Guerrier, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1137, guerriej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Oncology. 

Date: November 13–14, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street 

NW., Washington, DC 20036. 

Contact Person: Arnold Revzin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4146 

MSC 7824, Bethesda, MD 20892, 301–435– 

1153. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Resource for 

X-Ray Tomography of Whole Cells. 

Date: November 16–18, 2014. 

Time: 7:00 p.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Durant, 2600 Durant Avenue, 

Berkeley, CA 94704. 

Contact Person: Paul Sammak, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6185, 

MSC 7892, Bethesda, MD 20892, 301–435– 

0601, sammakpj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Basic Research on HIV Persistence. 

Date: November 17, 2014. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The St. Regis Washington, DC, 923 

16th Street NW., Washington, DC 20006. 

Contact Person: Robert Freund, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Risk, Prevention and Health 

Behavior. 

Date: November 17–18, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Martha M Faraday, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

3575, faradaym@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Basic Research on HIV Persistence. 

Date: November 17, 2014. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The St. Regis Washington, DC, 923 

16th Street NW., Washington, DC 20006. 

Contact Person: Kenneth A Roebuck, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5106, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1166, roebuckk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Oral, Dental, 

and Craniofacial Sciences SBIR/STTR. 

Date: November 18–19, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health. 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Yi-Hsin Liu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7814, Bethesda, MD 20892, 301–435– 

1781, liuyh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Fellowship: 

Cell Biology, Developmental Biology and 

Bioengineering. 

Date: November 18–19, 2014. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Alexander Gubin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4196, 

MSC 7812, Bethesda, MD 20892, 301–435– 

2902, gubina@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Academic 

Research Enhancement: Healthcare Delivery 

and Methodologies. 

Date: November 18, 2014. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Ping Wu, Ph.D., Scientific 

Review Officer, HDM IRG, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3166, 

Bethesda, MD 20892, 301–615–7401, wup4@

csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 14, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–24785 Filed 10–17–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Omnibus 

SEP–11. 

Date: November 18, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W610, Rockville, MD 20850, (Telephone 

Conference Call). 

Contact Person: Caterina Bianco, MD, 

Ph.D., Scientific Review Officer, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 9609 Medical Center Drive, Room 

7W610, Bethesda, MD 20892–9750, 240–276– 

6459, biancoc@mail.nih.gov. 


tkelley on DSK3SPTVN1PROD with NOTICES